Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature.

Cowden syndrome is a rare condition defined by multiple hamartomatous growths and a guarded prognosis owing to the high risk of cancer development. The syndrome is inherited as an autosomal dominant trait with incomplete penetrance and variable expressivity. The PTEN/MMAC1/TEP1 tumor suppressor gene on chromosome 10q23.3, has proven to contain a germline mutation predisposing for uncontrolled cell growth and survival via the PI3K/AKT pathway. Presented here is a case of Cowden syndrome in a patient with multiple hamartomas of the nose, midfacial skin and oral mucosa, and fissured tongue; plus a history of bipolar disease, iron deficiency anemia, basal cell carcinoma, fibroids of the uterus, and arthritis. The family history was significant for a daughter diagnosed with lung cancer. A final diagnosis of Cowden syndrome was made on the basis of established criteria and confirmed using immunohistochemistry directed against PTEN and phosphorylated-AKT.

[1]  J. L. Giunta.  Gingival fibrous nodule. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[2]  W. Steck,et al.  Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. , 1983, Journal of the American Academy of Dermatology.

[3]  T. Sugimura,et al.  Novel germline mutation of the PTEN gene in a Japanese family with Cowden disease , 2003, Journal of Gastroenterology.

[4]  A. Tarnawski,et al.  NSAIDs activate PTEN and other phosphatases in human colon cancer cells: novel mechanism for chemopreventive action of NSAIDs. , 2004, Biochemical and biophysical research communications.

[5]  C Eng,et al.  Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome , 2004, Journal of Medical Genetics.

[6]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[7]  C. Eng,et al.  Protean PTEN: form and function. , 2002, American journal of human genetics.

[8]  E. Asselin,et al.  Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. , 2004, International journal of oncology.

[9]  D. Marsh,et al.  Genetic insights into familial cancers-- update and recent discoveries. , 2002, Cancer letters.

[10]  G. Reifenberger,et al.  Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. , 2003, American journal of human genetics.

[11]  V. Ruocco,et al.  Early diagnosis of multiple hamartoma and neoplasia syndrome (Cowden disease). The role of the dentist. , 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[12]  B. Schmidt,et al.  Multiple pigmented lesions of the lower lip. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[13]  S. Mallory.  Cowden syndrome (multiple hamartoma syndrome). , 1995, Dermatologic clinics.

[14]  F. Arwert,et al.  The Cowden syndrome: a clinical and genetic study in 21 patients , 1986, Clinical genetics.

[15]  R. Spetzler,et al.  Cowden syndrome and lhermitte‐duclos disease , 1992, Cancer.

[16]  K. Lloyd,et al.  Cowden's disease. A possible new symptom complex with multiple system involvement. , 1963 .

[17]  W. Neville,et al.  Oral and Maxillofacial Pathology , 2004 .

[18]  J. Kuratsu,et al.  Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. , 2004, Cancer letters.

[19]  P. Weary,et al.  Multiple hamartoma syndrome (Cowden's disease). , 1972, Archives of dermatology.

[20]  M. Goluda,et al.  Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias. , 2002, Cancer letters.

[21]  M. Iida,et al.  Oral and facial lesions in Cowden's disease: report of two cases and a review of the literature. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[22]  P. Kelly.  Hereditary Breast Cancer Considering Cowden Syndrome: A Case Study , 2003, Cancer nursing.

[23]  Hong Sun,et al.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. , 1997, Cancer research.

[24]  S. Lautenschlager,et al.  Cowden Syndrome – Diagnostic Skin Signs , 2001, Dermatology.

[25]  Robert J. Gorlin,et al.  Syndromes of the Head and Neck , 1976 .

[26]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Botma,et al.  Cowden’s disease: a rare cause of oral papillomatosis , 2002, The Journal of Laryngology & Otology.

[28]  M. Beckmann,et al.  Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation , 2003, The British journal of dermatology.

[29]  L. Requena,et al.  Multiple sclerotic fibromas of the skin , 1992, Journal of cutaneous pathology.

[30]  E. Mariman,et al.  Localization of the gene for Cowden disease to chromosome 10q22–23 , 1996, Nature Genetics.

[31]  D. Bardenstein,et al.  Cowden's disease. , 1988, Ophthalmology.

[32]  A. Mehregan,et al.  Trichilemmomas in Cowden's disease. , 1977, JAMA.

[33]  O. Olopade,et al.  Male breast cancer in Cowden syndrome patients with germlinePTEN mutations , 2001, Journal of medical genetics.

[34]  A. Laquérriere,et al.  Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature. , 2004, Surgical neurology.

[35]  Y. Kubo,et al.  A novel PTEN mutation in a Japanese patient with Cowden disease , 2000, The British journal of dermatology.

[36]  R. Parsons,et al.  PTEN: life as a tumor suppressor. , 2001, Experimental cell research.

[37]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[38]  R. Hennekam,et al.  PTEN hamartoma tumour syndrome: variability of an entity , 2003, Journal of medical genetics.

[39]  K. Mishima,et al.  Solitary sclerotic fibroma of the lip , 2003, The British journal of dermatology.